| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.3M | -95.5% |
| R&D Expense | $19.6M | +5.9% |
| SG&A Expense | $11.8M | +0.9% |
| Operating Income | -$30.3M | -4728.9% |
| Net Income | -$32.9M | -8862.5% |
| EPS (Basic) | -$0.55 | -5600.0% |
| EPS (Diluted) | -$0.55 | -5600.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $48.3M | +58.6% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $49.4M | +17.2% |
| Total Assets | $51.3M | +19.6% |
| Current Liabilities | $5.8M | +24.6% |
| Total Liabilities | $40.7M | +725.8% |
| Stockholders' Equity | $10.6M | -72.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.4M | -24.5% |
| Capital Expenditures | $246K | — |
| Investing Cash Flow | -$246K | — |
| Financing Cash Flow | $31.3M | +31.8% |
| Free Cash Flow | -$13.6M | -26.8% |